Clariscan, an MRI contrast agent made by General Electric (GE), contains gadolinium, a chemical that has been found to remain in the body for long periods of time, causing a number of severe health effects.
Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with any form of gadolinium retention, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What is Clariscsn?
Clariscan belongs to a group of chemical substances known as “contrast agents” which are used in millions of magnetic resonance imaging (MRI) scans and other similar medical procedures each year in the U.S. The chemical is used to improve the contrast of images obtained during the MRI scan. Clariscan is manufactured by General Electric, and was approved by the FDA in March 2017.
What’s the problem?
The problem is that gadolinium contrast dyes like Clariscan have been found to remain in the body after the medical procedure, accumulating in the patient’s bones, brain, and other vital organs. This is referred to as gadolinium retention, and is caused by separation of the gadolinium from the rest of the GBCA compound, preventing it from being expelled. While some patients are able to pass gadolinium through urination, others are not, and the chemical remains in their body indefinitely, which, over time, leads to severe health consequences including gadolinium storage condition and gadolinium deposition disease.
Signs and Symptoms
Symptoms of gadolinium deposition disease / gadolinium storage condition include:
- Bone pain
- Skin and subcutaneous tissue burning pain
- “Chemo brain” or “brain fog”
- Skin changes
- Thickening / discoloration of the skin
FDA Warning on Gadolinium Dyes
The FDA in December 2017 issued a Public Health Alert stating that it was requiring stronger warnings for patients and more intensive guidelines for medical professionals about the risk of gadolinium toxicity. Additionally, the European Medicines Agency (EMA) has recommended the suspension of marketing authorizations for at least 4 linear GBCAs.
Why Our Firm is Filing Individual Clariscan Lawsuits Instead of a Class Action
Although Schmidt & Clark, LLP, is a nationally recognized class action firm, we have decided against the filing of a class action lawsuit in the Clariscan litigation, and are only entering individual complaints against the manufacturer. It has been our experience that these types of cases yield significantly better payouts, as well as give each client more say in his or her own case, when handled on an individual basis. If you feel you’ve been injured, you should contact our lawyers today to learn about your legal rights.
Which Other Brands of MRI Dyes Contain Gadolinium?
In addition to Clariscan, other gadolinium contrast agents include:
- And others
Do I Have a Clariscan Class Action Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Clariscan lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Case Evaluation: Again, if you had any form of gadolinium retention from Clariscan, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.